Hypochlorous acid, a microbe-killing chlorine compound that white blood cells make, is sold as weak cleansing sprays, rinses and gels for skin, eyelids, mouth and wounds. Rinsing surgical wounds has the strongest human evidence, with fewer infections than plain salt water. Evidence for ulcers, eyelids, acne and gums is modest. Risks are mostly brief stinging or dryness; real hazards come from misuse. It does not act on aging directly. (Full Review)

Protocol

Eyelid hygiene (standard)

0.01%, twice daily for 4 weeks

Sprayed onto closed lids or a pad and wiped along the lash line; then once daily for maintenance

Skin care and post-procedure

0.01–0.02% mist, 1–3 times daily

On clean skin; after laser or surgery, twice daily for 1–2 weeks

Oral rinse

10–15 mL of 0.025–0.05%, twice daily

30–60 seconds after brushing; up to 3 weeks after periodontal (gum) surgery

Time to effect

Chronic ulcers

4–24 weeks

Diabetic foot ulcer healing, as an add-on to standard care

Acne

Several weeks

Response in inflammatory acne lesions, as assessed in trials

Acute wounds

Within days

Faster early skin closure than saline, equalizing by day 10

Benefits

High: Fewer surgical site infections with irrigation during surgery

Medium: Faster healing of chronic ulcers and acute skin wounds; reduced inflammatory acne lesions; better-tolerated eye antisepsis than povidone-iodine; plaque control and comfort after oral surgery; faster healing of fungal corneal ulcers; higher Helicobacter pylori eradication with oral hygiene

Low: Lower eczema severity with dilute hypochlorite baths; itch relief; blepharitis and dry-eye symptom relief; sinus and nasal symptom relief with nasal irrigation; improved scar appearance

Speculative: Lower respiratory virus load via mouth rinse; protection against sun-induced skin cancer; killing of bacteria within eyelid biofilms

Contraindications

Documented allergy to chlorine or hypochlorite products (prior positive patch test or reaction)

Asthma or chronic obstructive pulmonary disease (COPD), for any misted, fogged or nebulized use (for example, FEV1 below 80% of predicted or recent exacerbation)

Fresh surgical incisions, for strongly acidic electrolyzed solutions (pH below 3)

Oral ingestion at any concentration (including children with access to home generators)

Mixing with vinegar, acidic descalers or ammonia cleaners (absolute contraindication)

Key Interactions

Topical retinoids (tretinoin, adapalene) and azelaic acid: added irritation (caution)

Eye drops (cyclosporine, lotilaner): may be diluted or oxidized (monitor for reduced effect; spacing 10 to 15 minutes apart limits this)

Chlorhexidine: forms a brown precipitate containing para-chloroaniline (caution)

Benzoyl peroxide, hydrogen peroxide, alcohol toners, exfoliating acids (glycolic, salicylic): added dryness and irritation (caution)

Topical antioxidants (vitamin C serums, N-acetylcysteine, glutathione): neutralize its antimicrobial effect (monitor; gap of at least 10 minutes)

Tea tree oil eyelid products, manuka honey wound dressings: added antimicrobial action and irritation (caution)

Contact lenses and metal instruments: irritation under soft lenses, corrosion of some metals (caution; 10 minutes before lens reinsertion)

Risk & Side Effects

Medium: Local stinging, dryness and unpleasant taste; impaired wound healing with strongly acidic solutions

Low: Airway irritation from misting, fogging or nebulizing; toxic gas when mixed with acids or ammonia; injury from concentrated or mislabeled hypochlorite; contact allergy

Speculative: Disruption of beneficial skin and eyelid bacteria; cumulative oxidative protein damage

Monitoring

Marker	Target	Why
OSDI score	Below 13	Tracks eyelid and dry-eye symptoms
Tear break-up time	More than 10 seconds	Measures tear-film stability
Wound area	At least 50% reduction by week 4	Early shrinkage predicts full closure
HbA1c	4.8–5.4%	Blood-sugar control governs healing
Skin or wound Staphylococcus aureus culture	No established target; change from own baseline is tracked	Colonization drives eczema flares and wound infection

Cadence: Baseline before starting (HbA1c for chronic wounds); symptoms and photographs at 2 weeks, 4 weeks, then every 3 months while use continues; wounds measured weekly. No routine blood tests are needed for topical hypochlorous acid itself.

Qualitative Assessment

Less eyelid burning, grittiness and morning crusting
Reduced redness, itch and stinging after procedures or in eczema-prone skin
Fewer new inflammatory acne lesions
Steady wound shrinkage with less odor and drainage
Good tolerance: no persistent stinging, dryness, cough or chest tightness

Hypochlorous Acid for Health & Longevity

Protocol

Benefits

Risk & Side Effects

Monitoring

Qualitative Assessment